Service Search Product Search Gene Search
HOME

SERVICES

• Protein Biotinylation Service • Custom Lysate Preparation Service • Immunogenicity Test Service > Anti-Drug Antibody (ADA) Evaluation Service > Neutralizing Antibody (NAb) Test Service • Anti-Drug Antibody (ADA) Evaluation Service • Neutralizing Antibody (NAb) Test Service • Thanksgiving Day Sale • Enzyme Target & Activator & Inhibitor Screening Service • GPCR Screening Service • Ion Channel Screening Service • Bio-layer Interferometry (BLI) Service • Electrophoretic Mobility Shift Assay (EMSA) Service • Transcription Factor Analysis > Electrophoretic Mobility Shift Assay (EMSA) Service > Chromatin Immunoprecipitation (ChIP) Assay Service > DNase I Footprinting Assay Service • Transporter Screening Service • Chromatin Immunoprecipitation (ChIP) Assay Service • Enzyme Activity Assay Service • DNase I Footprinting Assay Service • Co-Immunoprecipitation (Co-IP) • Surface plasmon resonance (SPR) Service • Pull Down Assay • Protein Mutant Library Construction • C1 Expression System • Protein Conjugation Service on Beads • Bacteria Expression • Yeast Expression • Mammalian Cell Expression • Insect Cell Expression • Animal-free Expression • Cell-free protein expression • Large-scale Protein Production • PEGylation Products and Services > Custom PEGylation Services > PEGylation Products • Basic Protein Characterization • Protein Labeling • Stable Cell Line Construction for Protein Expression • Protein Mutagenesis • Protein Interaction Analysis Services > Bio-layer Interferometry (BLI) Service > Co-Immunoprecipitation (Co-IP) > Surface plasmon resonance (SPR) Service > Pull Down Assay > Yeast Two-Hybrid Screening > Membrane-based Yeast Two-Hybrid Screening > CLIP-Seq Service > Protein Binding Site Mapping • Yeast Two-Hybrid Screening • Membrane-based Yeast Two-Hybrid Screening • Recombinant Protein or Antibody Production • Protein Expression Systems > Nicotiana tabacum Expression System > Bacterial Expression Systems(E. coli / Bacillus) > Yeast Expression Systems(P pastoris / S cerevisiae) > Baculovirus-insect Cell Expression Systems > Mammalian Expression Systems(CHO / 293) • PEGylation Services • Stable Cell Line Construction for Protein Expression • Process Development • cGMP Manufacturing • QC and QA • Bacterial Manufacturing • CLIP-Seq Service • Protein Binding Site Mapping • Quantum Dot Labeling • Protein Expression > Custom Lysate Preparation Service > C1 Expression System > Protein Co-expression Service in E. coli System > Protein Co-expression Service in Mammalian Cells > Trimeric Protein Production Service • Protein Co-expression Service in E. coli System • Protein Co-expression Service in Mammalian Cells • NovEgg Expression System • ADME/Tox Prediction • Pharmacophore Modeling • Screening and Profiling Services > Enzyme Target & Activator & Inhibitor Screening Service > GPCR Screening Service > Ion Channel Screening Service > Transporter Screening Service • Trimeric Protein Production Service • Incorporation of Bioorthogonal Handles > Incorporation of Unnatural Amino Acids > Incorporation of Unnatural Sugars > Direct Chemical Modification • Incorporation of Unnatural Amino Acids • Incorporation of Unnatural Sugars • Protein/peptide Crosslinking > Enzymatic Crosslinking Services > Photocrosslinking Services > Chemical Crosslinking Services • Enzymatic Crosslinking Services • Photocrosslinking Services • Chemical Crosslinking Services • Direct Chemical Modification • Protein-fluorophore Bioconjugation • Custom PEGylation Services • PEGylation Products • Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC) • Induced Protein Degradation > Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC) > Hydrophobic Tag Services > Destabilization Domains (DDs) • Hydrophobic Tag Services • Destabilization Domains (DDs) Nicotiana tabacum Expression System

CONTACT US

Tel: 1-631-448-8149
Fax: 1-631-938-8127

Biosimilar Testing Services

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval. Unlike with generic drugs of the more common small-molecule type, biosimilars generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. That is why you need accurate analysis at every stage.

A biosimilar marketing application should be submitted under the 351(k) section of the Public Health Service (PHS) act. To prove biosimilarity, such an application must include information about analytical studies, animal data, and clinical studies. According to section 351(k) of the PHS act, analytical testings should "demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components." Understandably, analytical testings should be a crucial first step in a biosimilar development program.

Biosimilar development pipeline

Biosimilar development  pipeline

Profacgen provides a one-stop solution for biosimilar testing, including Toxicology, TK and Immunogenicity assessment. We have developed more than a dozen biologics/ biosimilar for toxicology studies. Ranging from determining the exact sequence, structure and quality attributes of the originator to comparative head-to-head biosimilarity testing of the biosimilar with the originator, our biosimilar testing services provide vital analytics.

Profacgen offers following Biologics/Biosimilar services.

  Protein Physico-chemical Properties
Molecular mass: Ultracentrifugation, SDS-PAGE, SE-HPLC, Laser light scattering;
Isoforms: Isoelectric focusing, Capillary electrophoresis, IE-HPLC;
Extinction coefficient determination and validation.
  Protein Structure Analyses
Primary structure: Edman degradation, Peptide mapping with LC-MS, C-terminal sequencing, Amino acid analysis;
Secondary structure: Peptide mapping with reduced/non-reduced hydrolysis and Edman degradation or MS analysis to show disulphide bonding and other structural forms, Near Ultraviolet Circular Dichroism;
Tertiary and Quaternary structure: Far Ultraviolet Circular Dichroism, NMR, FTIR, X-Ray crystallography;
Free thiol determination;
Carbohydrate structure: Including enzymatic glycan cleavage and MALDI-MS, chromatography;
Glycosylation detection/fingerprinting;
Characterization of Post Translational Modifications;
Crystal structure with microscopy.
  Biological activities
In vivo activity: measuring therapeutic effect in animals;
In vitro activity: measuring therapeutic effect in cells: cell proliferation, inhibition of proliferation, cell senescence, measurable changes in cell size or content;
Enzyme assays;
Receptor-binding assays;
Promotion or inhibition of coagulation: chromogenic or turbidimetric techniques.

 

Our integrated biosimilar development services are based on a step-by-step approach to help you move seamlessly through the critical stages of development – from product characterization and biosafety testing, to full comparability studies and clinical trials, including bioanalytical and bioassay. We customize the service according to the specific requirements from the customers. Please do not hesitate to contact us for more details about our membrane protein modeling service.

 

CONTACT US
Email: info@profacgen.com
Tel: 1-631-448-8149
Fax: 1-631-938-8127
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA